Evidence map›Paper›PMID 32802176›Full record

ReviewTheranostics2020

Silver nanoparticles: Synthesis, medical applications and biosafety.

Li Xu, Yi-Yi Wang, Jie Huang, Chun-Yuan Chen, Zhen-Xing Wang, Hui Xie

Open access · goldAbstract readReview
In one paragraph

Review in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 397 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
397citing papers in PubMed, 2 pooled it
44.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

397 citing papers in PubMed, 2 syntheses or guidelines pooled it, 1,205 citations in OpenAlex.

  1. Pooled it
  2. Use of Antimicrobial Silver Coatings on Fixed Orthodontic Appliances, Including Archwires, Brackets, and Microimplants: A Systematic Review.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Antimicrobial Effect of Silver Nanoparticles Capped withNanomaterials (Basel, Switzerland) · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

337 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Li XuDepartment of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Yi-Yi WangDepartment of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Jie HuangDepartment of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Chun-Yuan ChenDepartment of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Zhen-Xing WangDepartment of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Hui XieDepartment of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Central South University · CNXiangya Hospital Central South University · CNHunan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver nanoparticles (AgNPs) have been one of the most attractive nanomaterials in biomedicine due to their unique physicochemical properties. In this paper, we review the state-of-the-art advances of AgNPs in the synthesis methods, medical applications and biosafety of AgNPs. The synthesis methods of AgNPs include physical, chemical and biological routes. AgNPs are mainly used for antimicrobial and anticancer therapy, and also applied in the promotion of wound repair and bone healing, or as the vaccine adjuvant, anti-diabetic agent and biosensors. This review also summarizes the biological action mechanisms of AgNPs, which mainly involve the release of silver ions (Ag

Indexed as

AnimalsHumansMetal NanoparticlesPharmaceutical PreparationsReactive Oxygen SpeciesSilverWound HealingPharmaceutical PreparationsReactive Oxygen SpeciesSilverAnticancerAntimicrobialMechanismsSilver Ångstrom particlesSilver nanoparticlesSynthesisToxicity

Identifiers

PMID32802176
PMCPMC7415816
OpenAlexW3044700892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.